Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebral Hemodynamics- ICHOR II

NCT04435834 is registered in ClinicalTrials.gov with Matthew Borzage as lead sponsor.

NCT NCT04435834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebral Hemodynamics- ICHOR II
Lead sponsor
Matthew Borzage
Phase
Phase 4
Overall status
Recruiting
Start date
June 9, 2020
Completion date
September 10, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, anesthesia; reaction